Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design.

Journal of Medicinal Chemistry
Matteo MoriFiorella Meneghetti

Abstract

The Mg2+-dependent Mycobacterium tuberculosis salicylate synthase (MbtI) is a key enzyme involved in the biosynthesis of siderophores. Because iron is essential for the survival and pathogenicity of the microorganism, this protein constitutes an attractive target for antitubercular therapy, also considering the absence of homologous enzymes in mammals. An extension of the structure-activity relationships of our furan-based candidates allowed us to disclose the most potent competitive inhibitor known to date (10, Ki = 4 μM), which also proved effective on mycobacterial cultures. By structural studies, we characterized its unexpected Mg2+-independent binding mode. We also investigated the role of the Mg2+ cofactor in catalysis, analyzing the first crystal structure of the MbtI-Mg2+-salicylate ternary complex. Overall, these results pave the way for the development of novel antituberculars through the rational design of improved MbtI inhibitors.

References

Jan 1, 1987·Analytical Biochemistry·B Schwyn, J B Neilands
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Juan-Carlos PalominoFrançoise Portaels
Aug 12, 2003·Proteins·Marcel L VerdonkRichard D Taylor
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Oct 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·M Sloan SiegristEric J Rubin
Jan 9, 2010·Acta Crystallographica. Section D, Biological Crystallography·Vincent B ChenDavid C Richardson
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Jun 1, 2010·ChemMedChem·Alexandra Manos-TurveyRichard J Payne
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Martyn D WinnKeith S Wilson
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Clemens VonrheinGérard Bricogne
Feb 7, 2012·Physical Chemistry Chemical Physics : PCCP·Silvia FerrerJuan Bertrán
May 26, 2012·Science·P Andrew Karplus, Kay Diederichs
Jun 10, 2016·Current Medicinal Chemistry·Fiorella MeneghettiLuca Costantino
Jul 5, 2016·Journal of the American Chemical Society·Kathleen M MeneelyAudrey L Lamb
Feb 9, 2017·Acta Crystallographica. Section D, Structural Biology·Fei LongGarib N Murshudov
Mar 11, 2017·The Journal of Organic Chemistry·Xiao-Kang ZhangCourtney C Aldrich
Apr 19, 2017·Chemical Biology & Drug Design·Federica PortaStefania Villa
Jun 24, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Elena PiniDaniela Barlocco
Jun 26, 2018·European Journal of Medicinal Chemistry·Laurent R ChiarelliFiorella Meneghetti
Nov 27, 2018·Chemical Reviews·Alex ChaoCelia W Goulding
Mar 21, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Laurent R ChiarelliFiorella Meneghetti
Dec 11, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Patrick WeberAhmed Haouz

❮ Previous
Next ❯

Citations

Dec 30, 2020·Journal of Medicinal Chemistry·Mousumi ShyamVenkatesan Jayaprakash
Aug 17, 2021·European Journal of Medicinal Chemistry·Giulia CazzanigaStefania Villa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.